rct¶¼ÓÐʲôϵÁÐ?

RCT-378¡¢RC-402ºÍRCT-424µÄÉè¼ÆÖУ¬ÄÐÐÔ½ÇÉ«ÆÕ±éÉí²Ä°«Ð¡£¬ÊôÓÚÙªÈåÀàÐÍ£¬¶øÅ®ÐÔ½ÇÉ«ÔòÏà¶Ô½Ï¸ß£¬Éí¸ßͨ³£ÔÚ170ÀåÃ×ÒÔÉÏ¡£ÕâÖÖÉè¼Æ³ÊÏÖ³öÃ÷ÏÔµÄÐÔ±ð²îÒ죬ٸßÄе͵ÄÉ趨...

rctϵÁоçÇé×îÓÐÒâ˼µÄ?

ÔÚRCTϵÁÐÖУ¬¼¸Î»½ÇÉ«µÄÉí¸ß²îÒìÎÞÒÉΪ¾çÇéÔöÌíÁ˶ÀÌØµÄȤζÐÔ¡£Ê×ÏÈÊÇRCT-378ºÍRC-402£¬ËûÃÇÒÔÄÐÐÔ½ÇÉ«ÆÕ±é°«Ð¡ÎªÌص㣬Éí¸ßÃ÷ÏÔµÍÓÚÆ½¾ùÖµ£¬ÐγÉÏÊÃ÷µÄÊÓ¾õ¶Ô±È¡£Óë´Ë...

ÈçºÎÅжϵÍѪÌÇ?

WISDM RCT »ùÏß½á¹û£ºÀÏÄêT1DµÍѪÌÇ·¢ÉúÂʸߣ¬µÍѪÌÇÒâʶ½µµÍÕß»ò¾­ÀúƵ·±ºÍ¼«¶ËµÍѪÌÇÑо¿µÄRCT½×¶Î·ÖÎöÁËÀ´×ÔÃÀ¹ú22¸öÁÙ´²Õ¾µãµÄ203Ãû²ÎÓëÕßµÄ...

PYcharm±¨´íinvalid type - ÓÐÎʱشð - CSDNÎÊ´ð

PYcharm±¨´íinvalid typeÕâ¸öÒªÔõô¼ì²é

RÁÐ?ÓÐʲô´ú±í,Çë¾ÙÀý½²½²,ÒÔ¼°ÄãµÄ¸öÈËÆÀ¼Û!

ÔÚRÁÐÖУ¬Ò»Ð©Ìض¨µÄ´úÂëÈçRCT-378¡¢RC-402ºÍRCT-424£¬ÆäÌØµãÔÚÓÚ´ú±íÁËÉí¸ßÌØÕ÷¡£ÄÐÐÔ¸öÌåÔÚÕâÀà´úÂëÖÐͨ³£±íÏÖΪ°«Ð¡£¬¶øÅ®ÐÔÔòÏà¶Ô½Ï¸ß£¬±ÈÈ糬¹ý170ÀåÃס£ÕâÖÖÄа«...

Ææ¼£¸ÅÂÊż·¢Ê¼þ

RCT-378 ÖÐÎÄ×ÖÄ» RCT-402 õÎõΰå ÖÐÎÄ×ÖÄ» RCT-424 ÓÎÓ¾³Ø ÖÐÎÄ×ÖÄ» RCT-470 »¬»¬ÌÝ

³ÐÊÔ×ÊÖÊÒ»ÖÁÎå¼¶ÊÔÑéÉ豸ÅäÖÃÈ«¹úͨÓðæ - °Ù¶È¾­Ñé

ÓÍ¿ª¹Ø7PH²âÊÔÒÇPH335Óͽþ±äѹÆ÷£¬ÓÍ¿ª¹Ø8¾øÔµÓͽéÖÊËðºÄ²âÊÔÒÇNRYJS-6600¾øÔµÓͽéÖÊËðºÄ²âÁ¿9¾øÔµÓͽéµçÇ¿¶È²âÊÔÒÇNRJY-80kV¾øÔµÓ͵ÄÄÍѹ²âÁ¿10ÖÇÄܵ絼ÑÎÃܲâÊÔÒÇNRCT-Z¾øÔµ×ÓÑÎ...

STROBEÉùÃ÷:¹Û²ìÐÔÑо¿±¨¸æ¹æ·¶ - °Ù¶È¾­Ñé

STROBEÉùÃ÷£º¹Û²ìÐÔÑо¿±¨¸æ¹æ·¶ 1 ËäÈ»¹Û²ìÐÔÑо¿ÔÚѭ֤ҽѧÖеĵȼ¶²»ÈçËæ»ú¶ÔÕÕÑо¿(RCT),µ«ºÜ¶àÁÙ´²ÎÊÌâ(È粡Òò¡¢Õï¶Ï¡¢Ô¤ºóµÈ)ÐèÒªÒÀ¿¿¹Û²ìÐÔÑо¿...

ÓÐûÓдóÉñ¿ÉÒÔϵͳµÄ½²Ò»ÏÂÄÚÉúÐÔÎÊÌâºÍ¹¤¾ß±äÁ¿...

µ«RCTµÄÎÊÌâÊÇ£ºÊµÑé³É±¾Ì«¸ß£¬ÇÒ¿ÉÄÜÓеÀµÂºÍÂ×Àí·çÏÕ£¬ËùÒÔÒ»°ã¼ÆÁ¿¾­¼Ãѧ²»Ì«È¥Óá£2.PSM£¨ÇãÏòµÃ·ÖÆ¥Å䣩ÕâÖÖ·½·¨£¬¿ÉÒÔ˵ÊÇ¡°·ÇʵÑ顱°æ...

Òý·¢¸ÉÑÛÖ¢µÄ¹Ø¼üÒòËØÊÇʲô?

1%) for dry eye.Ophthalmology. 2000;107(4):631¨C639.PubMedHolland EJ, et al. OPUS-3: Lifitegrast 5.0% phase III RCT in dry...378:1681¨C1690. £¨ÒõÐÔ½á¹û£©ÐÂÓ¢¸ñÀ¼Ò½Ñ§ÔÓÖ¾Stapleton F, et al. TFOS DEWS II Epidemiology Report.Ocul Surf. 2017;15(3):334¨C365....

Ïà¹ØËÑË÷